Check-Cap Ltd. (CHEK)

USD 0.65

(-0.78%)

Total Liabilities Summary of Check-Cap Ltd.

  • Check-Cap Ltd.'s latest annual total liabilities in 2023 was 1.33 Million USD , down -67.79% from previous year.
  • Check-Cap Ltd.'s latest quarterly total liabilities in 2023 FY was 1.33 Million USD , down -67.79% from previous quarter.
  • Check-Cap Ltd. reported annual total liabilities of 4.12 Million USD in 2022, down -16.89% from previous year.
  • Check-Cap Ltd. reported annual total liabilities of 4.96 Million USD in 2021, up 52.39% from previous year.
  • Check-Cap Ltd. reported quarterly total liabilities of 3.53 Million USD for 2023 Q2, down -17.58% from previous quarter.
  • Check-Cap Ltd. reported quarterly total liabilities of 1.33 Million USD for 2023 Q4, down -18.65% from previous quarter.

Annual Total Liabilities Chart of Check-Cap Ltd. (2023 - 2012)

Created with Highcharts 11.1.0YearsTotal Liabilities2012201320142015201620172018201920202021202220231000000 USD2000000 USD3000000 USD4000000 USD5000000 USD6000000 USD7000000 USD

Historical Annual Total Liabilities of Check-Cap Ltd. (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 1.33 Million USD -67.79%
2022 4.12 Million USD -16.89%
2021 4.96 Million USD 52.39%
2020 3.26 Million USD 2.03%
2019 3.19 Million USD 32.79%
2018 2.4 Million USD 20.24%
2017 2 Million USD 5.99%
2016 1.88 Million USD -28.75%
2015 2.65 Million USD -52.32%
2014 5.55 Million USD 32.84%
2013 4.18 Million USD 24.26%
2012 3.36 Million USD 0.0%

Peer Total Liabilities Comparison of Check-Cap Ltd.

Name Total Liabilities Total Liabilities Difference
Biodesix, Inc. 94.51 Million USD 98.593%
Castle Biosciences, Inc. 86.54 Million USD 98.463%
Exact Sciences Corporation 3.32 Billion USD 99.96%
IDEXX Laboratories, Inc. 1.77 Billion USD 99.925%
23andMe Holding Co. 206.64 Million USD 99.356%
NeoGenomics, Inc. 739.69 Million USD 99.82%
Neogen Corporation 1.44 Billion USD 99.908%
Inotiv, Inc. 588.04 Million USD 99.774%
Psychemedics Corporation 6.59 Million USD 79.842%
RadNet, Inc. 2.07 Billion USD 99.936%
Star Equity Holdings, Inc. 21.67 Million USD 93.864%
bioAffinity Technologies, Inc. 3.36 Million USD 60.491%
Illumina, Inc. 4.36 Billion USD 99.97%
Aspira Women's Health Inc. 8.62 Million USD 84.583%
Prenetics Global Limited 44.01 Million USD 96.978%
iSpecimen Inc. 6.07 Million USD 78.118%
OpGen, Inc. 13.44 Million USD 90.107%
T2 Biosystems, Inc. 62.83 Million USD 97.883%
Standard BioTools Inc. 159.86 Million USD 99.168%
Neuronetics, Inc. 81.64 Million USD 98.371%
Precipio, Inc. 3.67 Million USD 63.78%
Intelligent Bio Solutions Inc. 5.59 Million USD 76.232%
Exagen Inc. 34.25 Million USD 96.117%
Bionano Genomics, Inc. 118.24 Million USD 98.875%
CareDx, Inc 223.28 Million USD 99.404%
Twist Bioscience Corporation 152.97 Million USD 99.131%
Guardant Health, Inc. 1.62 Billion USD 99.918%
BioNexus Gene Lab Corp. 1.74 Million USD 23.648%
Natera, Inc. 691.79 Million USD 99.808%
Fulgent Genetics, Inc. 139.82 Million USD 99.049%
Sera Prognostics, Inc. 25.28 Million USD 94.74%
OPKO Health, Inc. 622.47 Million USD 99.786%
Personalis, Inc. 95.65 Million USD 98.61%
Aclaris Therapeutics, Inc. 40.22 Million USD 96.694%
Applied DNA Sciences, Inc. 8.77 Million USD 84.85%
Myriad Genetics, Inc. 312.9 Million USD 99.575%
ICON Public Limited Company 7.74 Billion USD 99.983%
Star Equity Holdings, Inc. 21.67 Million USD 93.864%
MDxHealth SA 121.92 Million USD 98.909%
Prenetics Global Limited 44.01 Million USD 96.978%
DarioHealth Corp. 38.24 Million USD 96.522%
ENDRA Life Sciences Inc. 1.09 Million USD -21.444%
Medpace Holdings, Inc. 1.09 Billion USD 99.879%
Mainz Biomed B.V. 12.15 Million USD 89.062%
Trinity Biotech plc 83.38 Million USD 98.405%
Sotera Health Company 2.68 Billion USD 99.95%
bioAffinity Technologies, Inc. 3.36 Million USD 60.491%